Shelton Capital Management Catalent, Inc. Transaction History

Shelton Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $774,379 - $950,031	-9,017 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$48.02 - $79.04 $14,454 - $23,791	-301 Reduced 3.23%	9,017 $661,000
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $350,984 - $484,637	8,940 Added 2365.08%	9,318 $505,000
Q1 2019 May 10, 2019	SELL	$29.84 - $43.92 $266,769 - $392,644	-8,940 Reduced 95.94%	378 $9.32 Million
Q3 2017 Nov 28, 2017	BUY	$33.75 - $41.67 $314,482 - $388,281	9,318 New	9,318 $372,000
Q3 2017 Nov 14, 2017	SELL	$33.75 - $41.67 $314,482 - $388,281	-9,318 Closed	0 $0
Q3 2016 Dec 04, 2017	BUY	N/A	9,318	9,318 $251,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.